Table Filtering
Other Information
Release Statistics Download
Guidelines
MIRAGE
Alliance of Genome Resources

Alliance of Genome Resources is a gene dataset, which contains curated genome information essential for the understanding of the genetics and genomic basis of human biology, health and disease. All data is retrieved from six major model organism databases and the Gene Ontology including FlyBase, Mouse Genome Database (MGI), Rat Genome Database (RGD), Saccharomyces Genome Database (SGD), WormBase, Zebrafish Information Network (ZFIN), and the GO Consortium. In GlyCosmos, only glycan-related disease information has been extracted from Alliance of Genome Resources.

Source Last Updated
Alliance of Genome Resources January 28, 2025
Displaying entries 1 - 25 of 14279 in total
Disease ID Disease Name Alliance of Genome Resources ID Species ▲ Gene ID Gene Symbol FlyGlycoDB Evidence References
DOID:12858 Huntington's disease WB:WBGene00018294 Caenorhabditis elegans 179246 atg-18 combinatorial experimental and author inference evidence used in manual assertion
  • PMID:17172799
DOID:809 cocaine abuse WB:WBGene00003386 Caenorhabditis elegans 179269 mod-1 mutant phenotype evidence used in manual assertion
  • PMID:19536276
DOID:14250 Down syndrome WB:WBGene00010757 Caenorhabditis elegans 259529 pad-2 mutant phenotype evidence used in manual assertion
  • PMID:15233996
DOID:9970 obesity WB:WBGene00001650 Caenorhabditis elegans 177850 gon-1 combinatorial experimental and author inference evidence used in manual assertion
  • PMID:34492009
DOID:9352 type 2 diabetes mellitus WB:WBGene00001650 Caenorhabditis elegans 177850 gon-1 mutant phenotype evidence used in manual assertion
  • PMID:26218657
DOID:1289 neurodegenerative disease WB:WBGene00010775 Caenorhabditis elegans 187297 poml-1 mutant phenotype evidence used in manual assertion
  • PMID:26941331
DOID:0050659 biotin-responsive basal ganglia disease WB:WBGene00044738 Caenorhabditis elegans 4363081 folt-3 mutant phenotype evidence used in manual assertion
  • PMID:17475669
DOID:1184 nephrotic syndrome WB:WBGene00006365 Caenorhabditis elegans 180555 syg-1 combinatorial experimental and author inference evidence used in manual assertion
  • PMID:20233749
DOID:1574 alcohol use disorder WB:WBGene00001172 Caenorhabditis elegans 179412 egl-3 mutant phenotype evidence used in manual assertion
  • PMID:19535903
DOID:809 cocaine abuse WB:WBGene00000295 Caenorhabditis elegans 180837 cat-1 combinatorial experimental and author inference evidence used in manual assertion
  • PMID:22642886
DOID:0060041 autism spectrum disorder WB:WBGene00003182 Caenorhabditis elegans 172732 mef-2 combinatorial experimental and author inference evidence used in manual assertion
  • PMID:22859820
DOID:9970 obesity WB:WBGene00001609 Caenorhabditis elegans 176286 glp-1 mutant phenotype evidence used in manual assertion
  • PMID:34492009
DOID:1289 neurodegenerative disease WB:WBGene00004033 Caenorhabditis elegans 181166 pkc-2 sequence orthology evidence used in manual assertion
  • PMID:28716951
DOID:206 hereditary multiple exostoses WB:WBGene00004360 Caenorhabditis elegans 178080 rib-1 mutant phenotype evidence used in manual assertion
  • PMID:17237233
DOID:2962 Cockayne syndrome WB:WBGene00008403 Caenorhabditis elegans 174474 csa-1 combinatorial experimental and author inference evidence used in manual assertion
  • PMID:25453470
DOID:9352 type 2 diabetes mellitus WB:WBGene00004049 Caenorhabditis elegans 266823 parp-1 mutant phenotype evidence used in manual assertion
  • PMID:29392078
DOID:1574 alcohol use disorder WB:WBGene00006797 Caenorhabditis elegans 172150 unc-63 combinatorial experimental and author inference evidence used in manual assertion
  • PMID:25342716
DOID:162 cancer WB:WBGene00002081 Caenorhabditis elegans 176296 ina-1 combinatorial experimental and author inference evidence used in manual assertion
  • PMID:21572423
DOID:14452 hypokalemic periodic paralysis WB:WBGene00000950 Caenorhabditis elegans 181035 deg-1 mutant phenotype evidence used in manual assertion
  • PMID:8994058
DOID:0080490 mucolipidosis type IV WB:WBGene00000846 Caenorhabditis elegans 176074 cup-5 mutant phenotype evidence used in manual assertion
  • PMID:11904372
  • PMID:16530747
  • PMID:20540742
DOID:1289 neurodegenerative disease WB:WBGene00001612 Caenorhabditis elegans 176204 glr-1 combinatorial experimental and author inference evidence used in manual assertion
  • PMID:31306683
DOID:2843 long QT syndrome WB:WBGene00006830 Caenorhabditis elegans 175527 unc-103 mutant phenotype evidence used in manual assertion
  • PMID:19038263
DOID:2978 carbohydrate metabolic disorder WB:WBGene00001645 Caenorhabditis elegans 179562 gly-20 sequence orthology evidence used in manual assertion
  • PMID:35586945
DOID:0090145 dopamine beta-hydroxylase deficiency WB:WBGene00000934 Caenorhabditis elegans 176304 dat-1 mutant phenotype evidence used in manual assertion
  • PMID:18768815
DOID:9870 galactosemia WB:WBGene00008132 Caenorhabditis elegans 173171 gale-1 mutant phenotype evidence used in manual assertion
  • PMID:25298520

About Release Notes Help Feedback

International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.4.0

Last updated: December 8, 2025